Pages that link to "Q36727182"
Jump to navigation
Jump to search
The following pages link to Targeting mammalian target of rapamycin (mTOR) for health and diseases. (Q36727182):
Displaying 50 items.
- Rab1A is an mTORC1 activator and a colorectal oncogene (Q24307749) (← links)
- Targeting the mTOR kinase domain: the second generation of mTOR inhibitors (Q24622194) (← links)
- Endoplasmic reticulum stress and the inflammatory basis of metabolic disease (Q24633352) (← links)
- mTOR inhibitors effects on regulatory T cells and on dendritic cells (Q26744447) (← links)
- Mammalian Target of Rapamycin: Its Role in Early Neural Development and in Adult and Aged Brain Function (Q26744655) (← links)
- Calcineurin inhibition and new-onset diabetes mellitus after transplantation (Q26865069) (← links)
- Rictor/TORC2 regulates Caenorhabditis elegans fat storage, body size, and development through sgk-1 (Q27331645) (← links)
- mTOR-independent 4E-BP1 phosphorylation is associated with cancer resistance to mTOR kinase inhibitors (Q27851707) (← links)
- Mechanisms of regulation of RNA polymerase III-dependent transcription by TORC1. (Q27936939) (← links)
- Judicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and Perspectives (Q28071388) (← links)
- Defective Autophagy, Mitochondrial Clearance and Lipophagy in Niemann-Pick Type B Lymphocytes (Q28109678) (← links)
- Factors underlying sensitivity of cancers to small-molecule kinase inhibitors (Q28252845) (← links)
- The susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposing (Q28476644) (← links)
- The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy (Q28579751) (← links)
- mTORC1 serves ER stress-triggered apoptosis via selective activation of the IRE1-JNK pathway (Q28583302) (← links)
- Big mice die young but large animals live longer (Q28704146) (← links)
- Why men age faster but reproduce longer than women: mTOR and evolutionary perspectives (Q28750492) (← links)
- Hyper-mitogenic drive coexists with mitotic incompetence in senescent cells (Q30533934) (← links)
- The interferon-gamma-mediated inhibition of lipoprotein lipase gene transcription in macrophages involves casein kinase 2- and phosphoinositide-3-kinase-mediated regulation of transcription factors Sp1 and Sp3. (Q33369658) (← links)
- Discovery of chemical modulators of a conserved translational control pathway by parallel screening in yeast (Q33498089) (← links)
- Alternative Perspectives on Aging in Caenorhabditis elegans: Reactive Oxygen Species or Hyperfunction? (Q33573959) (← links)
- Moderate lifelong overexpression of tuberous sclerosis complex 1 (TSC1) improves health and survival in mice (Q33678212) (← links)
- Conservation, duplication, and loss of the Tor signaling pathway in the fungal kingdom (Q33701049) (← links)
- Activation of the AMP-activated protein kinase-p38 MAP kinase pathway mediates apoptosis induced by conjugated linoleic acid in p53-mutant mouse mammary tumor cells (Q33727103) (← links)
- Allele-specific down-regulation of RPTOR expression induced by retinoids contributes to climate adaptations. (Q33741940) (← links)
- Immunosuppressive cyclosporin A activates AKT in keratinocytes through PTEN suppression: implications in skin carcinogenesis (Q33799731) (← links)
- Developing Antiepileptogenic Drugs for Acquired Epilepsy: Targeting the Mammalian Target of Rapamycin (mTOR) Pathway (Q33805859) (← links)
- Rapamycin extends maximal lifespan in cancer-prone mice (Q33816255) (← links)
- Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma (Q33818584) (← links)
- Identification of a novel MTOR activator and discovery of a competing endogenous RNA regulating autophagy in vascular endothelial cells (Q33878961) (← links)
- Reactive oxygen species in tumor necrosis factor-alpha-activated primary human keratinocytes: implications for psoriasis and inflammatory skin disease (Q33915587) (← links)
- Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells (Q34196369) (← links)
- Tailoring mTOR-based therapy: molecular evidence and clinical challenges (Q34294170) (← links)
- Integration analysis of quantitative proteomics and transcriptomics data identifies potential targets of frizzled-8 protein-related antiproliferative factor in vivo. (Q34318849) (← links)
- Protective role of p70S6K in intestinal ischemia/reperfusion injury in mice (Q34358639) (← links)
- TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists (Q34391710) (← links)
- Selective anti-cancer agents as anti-aging drugs (Q34392470) (← links)
- Telomerase expression abrogates rapamycin-induced irreversible growth arrest of uterine fibroid smooth muscle cells (Q34418102) (← links)
- Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies (Q34498303) (← links)
- Overnutrition, mTOR signaling, and cardiovascular diseases (Q34519316) (← links)
- Evaluation of the impact of the cancer therapy everolimus on the central nervous system in mice (Q34600979) (← links)
- Autophagy and cellular senescence mediated by Sox2 suppress malignancy of cancer cells (Q34603186) (← links)
- From nature to the laboratory and into the clinic (Q34657694) (← links)
- Caloric restriction promotes the reserve of follicle pool in adult female rats by inhibiting the activation of mammalian target of rapamycin signaling (Q34766166) (← links)
- FK506-binding protein 12 ligands: a patent review (Q34955459) (← links)
- Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis (Q35028378) (← links)
- Inhibition of protein kinase C delta attenuates allergic airway inflammation through suppression of PI3K/Akt/mTOR/HIF-1 alpha/VEGF pathway (Q35060705) (← links)
- Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD. (Q35147482) (← links)
- Targeted therapy in hepatocellular carcinoma (Q35207561) (← links)
- Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis (Q35216342) (← links)